XRCC1 and B-cell chronic lymphocytic leukemia: In chronic lymphocytic leukemia (CLL), Nrf2 activation can enhance the expression of DNA repair genes such as XRCC1 and POLB, which may contribute to disease progression and resistance to chemotherapy.